These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1971862)

  • 1. Gabapentin in partial epilepsy. UK Gabapentin Study Group.
    Lancet; 1990 May; 335(8698):1114-7. PubMed ID: 1971862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5.
    Neurology; 1993 Nov; 43(11):2292-8. PubMed ID: 8232945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
    Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
    Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
    Leach JP; Girvan J; Paul A; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (2):CD001415. PubMed ID: 10796785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures].
    Pierce MW; Shokry A
    Praxis (Bern 1994); 1997 Sep; 86(37):1430-1. PubMed ID: 9381042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
    Yamauchi T; Kaneko S; Yagi K; Sase S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
    Lindberger M; Alenius M; Frisén L; Johannessen SI; Larsson S; Malmgren K; Tomson T
    Epilepsia; 2000 Oct; 41(10):1289-95. PubMed ID: 11051124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.
    Leiderman DB
    Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group.
    Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin add-on for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (3):CD001415. PubMed ID: 10908495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89.
    Bergey GK; Morris HH; Rosenfeld W; Blume WT; Penovich PE; Morrell MJ; Leiderman DB; Crockatt JG; LaMoreaux L; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):739-45. PubMed ID: 9305334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid initiation of gabapentin: a randomized, controlled trial.
    Fisher RS; Sachdeo RC; Pellock J; Penovich PE; Magnus L; Bernstein P
    Neurology; 2001 Mar; 56(6):743-8. PubMed ID: 11274308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of gabapentin therapy in children with refractory partial seizures.
    Khurana DS; Riviello J; Helmers S; Holmes G; Anderson J; Mikati MA
    J Pediatr; 1996 Jun; 128(6):829-33. PubMed ID: 8648543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.